Cargando…
Proenkephalin A and bioactive adrenomedullin are useful for risk prognostication in cardiac surgery
INTRODUCTION: Various clinical scores have been developed to predict organ dysfunction and mortality in patients undergoing cardiac surgery, but outcome prediction may be inaccurate for some patient groups. Proenkephalin A (penKid) and bioactive adrenomedullin (bio-ADM) have emerged as promising bio...
Autores principales: | Hill, Aileen, Bergmann, Deborah, Schulte, Janin, Zayat, Rashad, Marx, Gernot, Simon, Tim-Philipp, Mossanen, Jana, Brücken, Anne, Stoppe, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900105/ https://www.ncbi.nlm.nih.gov/pubmed/36756642 http://dx.doi.org/10.3389/fcvm.2022.1017867 |
Ejemplares similares
-
Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
por: Molvin, John, et al.
Publicado: (2019) -
Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery
por: Mossanen, Jana C., et al.
Publicado: (2017) -
Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study
por: Simon, Tim-Philipp, et al.
Publicado: (2021) -
30 Days Mortality Prognostic Value of POCT Bio-Adrenomedullin and Proenkephalin in Patients with Sepsis in the Emergency Department
por: Casalboni, Silvia, et al.
Publicado: (2022) -
Assessing GFR With Proenkephalin
por: Beunders, Remi, et al.
Publicado: (2023)